Literature DB >> 22182209

Response rate and duration associated with a 4Gy 5 fraction palliative radiation protocol.

Catie McDonald1, Jayme Looper, Shawna Greene.   

Abstract

The purpose of this retrospective study was to determine if 4Gy fractions over 5 consecutive days is an effective and safe palliative radiation protocol for dogs and cats. Eighty patients (22 cats, 58 dogs) with complete follow-up information were evaluated. Overall response rate (ORR) for all patients was 67%. Median progression free survival (MPFS) was 3.3 months and median survival (MST) was 4.2 months. Primary bone tumors were the most common tumors treated. The ORR for primary bone tumors was 66.6%, the MPFS was 3.5 months, and MST was 3 months. The most common tumor treated in cats was oral squamous cell carcinoma and ORR was 54.5 %, the MPFS was 1.8 months, and MST was 3 months. Soft tissue sarcomas were the second most common tumor treated in dogs (10). ORR was 80% and the two other patients had stable disease. MPFS was 5.7 months and MST was 7.9 months. Overall rate of toxicity was 18.4% in 65 sites that were evaluated for toxicity. Acute toxicities were all grade I or II and occurred in 16.9 % of patients evaluated. All late toxicity was grade I alopecia and leukotrichia. There appears to be a comparable response rate for this palliative protocol as compared to others historically. This response was seen over a wide range of tumors. We also documented a low toxicity profile in a shorter overall treatment time, making this protocol more attractive for some clients.
© 2011 Veterinary Radiology & Ultrasound.

Entities:  

Mesh:

Year:  2011        PMID: 22182209     DOI: 10.1111/j.1740-8261.2011.01907.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  4 in total

1.  Recurrence analysis of intraoperative acridine orange-photodynamic therapy for dogs with intranasal tumors.

Authors:  Takuya Maruo; Yasuhiro Fukuyama; Yuta Nishiyama; Yuki Nemoto; Eiichi Kanai; Shinpei Kawarai; Hideki Kayanuma; Kensuke Orito
Journal:  Can Vet J       Date:  2021-10       Impact factor: 1.008

2.  A possible role of coarse fractionated radiotherapy in the management of gingival squamous cell carcinoma in dogs: A retrospective study of 21 cases from two referral centers in the UK.

Authors:  Andrea Mosca; Danielle Gibson; Sarah L Mason; Jane Dobson; Antonio Giuliano
Journal:  J Vet Med Sci       Date:  2021-01-25       Impact factor: 1.267

3.  Comparison of outcomes between medical and surgical treatment in dogs with prostatic adenocarcinoma: a retrospective study.

Authors:  Keigo Iizuka; Kumiko Ishigaki; Mamiko Seki; Takahiro Nagumo; Kei Tamura; Naoki Sakurai; Kazuyuki Terai; Kazushi Asano
Journal:  BMC Vet Res       Date:  2022-01-15       Impact factor: 2.741

4.  A naturally occurring feline model of head and neck squamous cell carcinoma.

Authors:  Jackie M Wypij
Journal:  Patholog Res Int       Date:  2013-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.